Skip to main content

Day: August 4, 2021

CenExel Clinical Research Acquires ForCare Clinical Research

Premier Dermatology Facility in Tampa Bay Joins the CenExel Centers of ExcellenceSalt Lake City, Utah, Aug. 04, 2021 (GLOBE NEWSWIRE) — CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of ForCare Clinical Research (“CenExel FCR”), a Tampa-based clinical research organization with Principal Investigators who have more than 40 years of combined research experience. CenExel FCR conducts Phase I through Phase IV studies in both chronic and acute conditions, primarily in Dermatology. By acquiring this state-of-the-art facility, CenExel dramatically strengthens its ability to support clinical research in Dermatology and Immunology, as well as several other therapeutic areas. CenExel FCR is led by Principal Investigators who are board certified and conduct studies in Dermatology, Immunology and...

Continue reading

Arbor Realty Trust, Inc. Announces Public Offering of Series E Cumulative Redeemable Preferred Stock

UNIONDALE, N.Y., Aug. 04, 2021 (GLOBE NEWSWIRE) — Arbor Realty Trust, Inc. (the “Company”) (NYSE:ABR) announced today that it plans to make a public offering of an initial issuance of its Series E Cumulative Redeemable Preferred Stock (the “Series E Preferred Stock”). In connection with the offering, the Company intends to grant the underwriters a 30-day option to purchase additional shares of Series E Preferred Stock to cover over-allotments, if any. The Company intends to file an application to list the Series E Preferred Stock on the NYSE under the symbol “ABR PrE” and, if approved, expects trading to commence within 30 days after the initial issuance of the Series E Preferred Stock. The Company intends to use the net proceeds from the offering to make investments relating to its business and for general corporate purposes. Raymond...

Continue reading

Beyond Meat® Expands Partnership With A&W Canada To Launch Plant-Based Chicken Nuggets Nationwide for a Limited Time Starting August 9

A&W Beyond Meat NuggetsA&W Beyond Meat NuggetsEL SEGUNDO, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) — Beyond Meat® (NASDAQ: BYND), a leader in plant-based protein, today announced another exciting milestone in its partnership with A&W Canada with the introduction of Beyond Meat Nuggets. The launch taps into the growing consumer demand for chicken from quick-service restaurants1 as well as an increased demand for plant-based proteins2. Beyond Meat Nuggets offer fans a crispy, craveable plant-based chicken nugget option with all the benefits of plant-based protein and no sacrifice on taste or flavour. Perfect for dipping, dunking and sharing, Beyond Meat Nuggets offer the same universally loved experience as traditional chicken nuggets while offering 18 grams of plant-based protein per six pieces. Like...

Continue reading

Proofpoint’s Annual Human Factor Report Reveals How 2020 Transformed Today’s Threat Landscape

More than 48 million observed messages containing malware capable of downloading ransomware foreshadowed the risk of recent high-profile cyber attacks SUNNYVALE, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) — Proofpoint, Inc. (NASDAQ: PFPT), a leading cybersecurity and compliance company, today unveiled its annual Human Factor report, which provides a comprehensive examination of the three main facets of user risk—vulnerability, attacks, and privilege—and how the extraordinary events of 2020 transformed the current threat landscape. Human Factor 2021 draws on data and insight from a year’s worth of research, covering threats detected, mitigated, and resolved across one of the largest datasets in cybersecurity. “Attackers don’t hack in, they log in, and people continue to be the most critical factor in today’s cyber attacks. The threat...

Continue reading

CUMULUS MEDIA Announces Completion of the Sale of Non-Core Nashville Real Estate for $34 Million

ATLANTA, Aug. 04, 2021 (GLOBE NEWSWIRE) — Cumulus Media Inc. (NASDAQ: CMLS) today announced that it has successfully completed the sale of non-core real estate in Nashville to a partnership comprised of Centrum Realty and Development, LLC, and Nashville Capital Group, LLC, for $34 million in gross proceeds. Francisco J. Lopez-Balboa, Executive Vice President and Chief Financial Officer of CUMULUS MEDIA, said, “We are very pleased to complete this nicely accretive non-core asset sale on a swift timeline at a value that exceeded expectations. This transaction is yet another example of our relentless focus on positioning the Company for maximum strategic and financial flexibility by continuing to de-lever the balance sheet, enhance liquidity and execute our multiple growth initiatives.” With the net proceeds from the transaction,...

Continue reading

HARVIA WILL PUBLISH ITS HALF-YEAR REPORT FOR JANUARY−JUNE 2021 ON THURSDAY, 12 AUGUST 2021 AT AROUND 9.00 A.M. EET

Harvia Plc press release 4 August 2021 at 3:00 P.M. EETHarvia will publish its half-year financial report for the period of January−June 2021 on Thursday, 12 August 2021 at around 09:00 a.m. Finnish time. The stock exchange release and the presentation material will be available after publishing at https://harviagroup.com/investor-relations/. Harvia will hold a webcast for analysts, investors and media on 12 August 2021 at 11:00 a.m. EET. The conference will be held in English. Harvia’s CEO Tapio Pajuharju and CFO Ari Vesterinen will host the event. The webcast can be followed at https://harvia.videosync.fi/2021-q2-results You can also participate in the conference by calling: Finland: +358 981 710 310 Sweden: +46 856 642 651 UK: +44 333 300 0804 US: +1 631 913 1422 PIN: 46246229# A recording of the webcast will be available later at...

Continue reading

ICU Equipment Market to Hit USD 8.42 Billion in 2028 with 3.2% CAGR; Implementation of Artificial Intelligence to Boost Growth: Fortune Business Insights™

Key Players Covered in the ICU Equipment Market are General Electric Company (Chicago, U.S.), Koninklijke Philips N.V. (Amsterdam, Netherlands), Getinge AB (Sweden, Europe), Medtronic (Dublin, Ireland), Fresenius SE & Co. KGaA (Bad Homburg, Germany), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Shenzhen, China), HILL-ROM HOLDINGS, INC. (Indiana, U.S.), Medline Industries, Inc. (Illinois, U.S.), B. Braun Melsungen AG (Melsungen, Germany), Edwards Lifesciences Corporation (California, U.S.), Invacare Corporation (Ohio, U.S.) Pune, India, Aug. 04, 2021 (GLOBE NEWSWIRE) — The global ICU Equipment Market is set to gain momentum from the increasing technological developments in the field of critical care. Nowadays, artificial intelligence (AI) is being used extensively to develop novel equipment. In August 2020, for instance,...

Continue reading

Zynerba Pharmaceuticals to Present at the Canaccord Genuity 41st Annual Growth Conference

DEVON, Pa., Aug. 04, 2021 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Company management will participate in a fireside chat during the Canaccord Genuity 41st Annual Growth Conference being held virtually on Wednesday, August 11, 2021 at 1:30 p.m. ET. Investors interested in arranging a virtual meeting with the Company’s management during the conference should contact the Canaccord Genuity conference coordinator. A webcast of the fireside chat will be available under the Events & Webcasts tab of the Investors section of the Zynerba website at www.zynerba.com. An archived replay will be available on the Company’s website following the event for 60 days. About...

Continue reading

Newport Merger Sub, Inc. announces successful receipt of requisite consents relating to The New Home Company Inc.’s 7.250% Senior Notes due 2025

NEW YORK, Aug. 04, 2021 (GLOBE NEWSWIRE) — Newport Merger Sub, Inc. (the “Merger Sub”), an affiliate of certain investment funds managed by affiliates of Apollo Global Management, Inc. (together with its consolidated subsidiaries, “Apollo”), has received the requisite consents to amend certain terms of the Indenture, dated as of October 28, 2020, by and among The New Home Company Inc. (“The New Home Company”), the guarantors party thereto and U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by the First Supplemental Indenture dated as of February 24, 2021, the Second Supplemental Indenture dated as of March 9, 2021, the Officer’s Certificate dated as of February 24, 2021 and by the Global Security for the 7.250% Senior Notes due 2025, as further amended or supplemented (the “Indenture”) governing The...

Continue reading

ProMIS Neurosciences Issues Chairman’s Memorandum

Notes and comments after the first AAIC meeting in the era of approved disease-modifying therapies for Alzheimer’s Disease TORONTO and CAMBRIDGE, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, issued today a Chairman’s memorandum, commenting on highlights of the recent 2021 Alzheimer’s Association International Conference (AAIC) with relevance to ProMIS and summarizing the ProMIS poster/oral presentation contributions to the meeting. “We are in a new era in the fight against Alzheimer’s, ALS, and other neurodegenerative diseases,” stated Eugene Williams, Executive Chairman of ProMIS Neurosciences. “ProMIS and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.